To test whether depletion of these activated B cells also ameliorates AD, 5×FAD mice (35–47 weeks old, female) were i.p. injected with anti-CD20/B220 Ab or control IgG (n = 7–12) for 2 months. Here, PTPRC is linked to Alzheimer disease.